Prof. Dr. Turgay Çelikel
OncologyVerified
- 47+years exp.
English · Turkish
FromPrice on request
Free quote
60 seconds · no obligationView Profile
Cancer Surgery
Lung cancer surgery
A detailed guide to lung cancer surgery in Turkey. Learn about surgical resection techniques including lobectomy, segmentectomy, and minimally invasive VATS or robotic procedures, clinical eligibility and lung function testing, approximate treatment costs across Europe and Turkey, hospital trip timelines, post-operative chest tube management, potential risks, and essential questions for your thoracic oncology team.
A written plan with the surgeon's name and the full price — usually within 24 hours.
- Category
- Cancer Surgery
- Hospitals
- 2
- Verified
- 1
- Price from
- Price on request
Verified surgeons for Lung Cancer Surgery
1 doctor Compare doctors, ratings and prices — ask any of them for a free quote.
Lung cancer surgery in Turkey: what it is and how it works
Lung cancer surgery is an oncological operation to remove a malignant pulmonary tumour along with surrounding healthy tissue and regional lymph nodes. For early-stage non-small cell lung cancer (NSCLC), surgical resection provides the most definitive opportunity for long-term remission and cure. Rather than treating the entire body with systemic medication alone, surgery physically extracts the primary lesion before cancer cells spread through the bloodstream or lymphatic system. Hospitals in Turkey perform thoracic cancer surgery using modern open, video-assisted, and robotic techniques. For a wider view of cancer care, see our guide to oncology treatments in Turkey.
The surgical objective is achieving an R0 resection, meaning complete tumour removal with microscopic clear margins. Resections follow the anatomical structure of the lungs, removing a segment, an entire lobe, or occasionally a whole lung. This guide outlines surgical techniques, clinical evidence, comparative costs against the UK and Europe, recovery milestones, and safety considerations.
Types of lung cancer surgery: lobectomy, segmentectomy and pneumonectomy
Thoracic surgeons select an operation based on tumour size, location within the bronchial tree, and baseline breathing capacity:
- Lobectomy: Excision of an entire lung lobe. It remains the international standard for tumours over 2 centimetres or centrally located within a lobe, securing clear margins and lymph node staging.
- Segmentectomy: Anatomical removal of individual bronchovascular segments. It offers equivalent cancer control to lobectomy for peripheral tumours 2 centimetres or smaller while preserving healthy lung tissue.
- Wedge resection: Non-anatomical removal of a peripheral tumour with a margin of healthy tissue, suited to patients with limited breathing reserve.
- Pneumonectomy: Removal of an entire lung, reserved for central tumours involving major pulmonary vessels or the main bronchus where lobectomy is impossible.
While breast procedures such as a lumpectomy permit localised excision, lung surgery requires careful respect of pulmonary vascular and bronchial anatomy.
Does lung cancer surgery cure cancer? Evidence and survival rates
For early-stage non-small cell lung cancer (stages I and II), complete surgical resection provides the highest probability of cure. Clinical data from the European Society of Thoracic Surgeons (ESTS) and British Thoracic Society (BTS) show five-year survival rates exceeding 70% to 90% for stage IA tumours cleared with negative margins. Survival outcomes decline in higher stages or when regional lymph nodes are involved.
Surgery is rarely a standalone solution. Microscopic cancer cells can detach before surgery, which is why surgeons perform systematic mediastinal lymph node dissection. Pathological examination of these nodes guides stage-appropriate adjuvant treatment, including targeted therapies, immunotherapy, or chemotherapy. As with other oncological resections such as the removal of colon cancer, anatomical clearance combined with thorough lymphadenectomy offers the best long-term disease control. Surgery cannot cure stage IV metastatic disease.
Surgical approaches: VATS, robotic RATS or open thoracotomy?
Surgeons choose an operative approach based on tumour size, chest anatomy, and surgical history:
- VATS (Video-Assisted Thoracoscopic Surgery): Performed through one to three small incisions (1 to 4 centimetres) using a camera and fine instruments. VATS reduces blood loss, postoperative pain, and hospital stay compared with open surgery.
- Robotic RATS: The surgeon directs articulated robotic instruments from a console, gaining 3D visualisation and high precision for delicate vascular and lymph node dissection.
- Open thoracotomy: An open incision between the ribs, reserved for large tumours, chest wall invasion, complex vascular sleeve reconstructions, or emergency bleeding control.
All procedures use general anaesthesia with a double-lumen endotracheal tube, deflating the operative lung while the other lung maintains ventilation. Surgery typically takes two to four hours.
Lung cancer surgery cost in Turkey compared with the UK, US and Germany
The cost of thoracic cancer surgery depends on hospital facilities, surgical technique (open, VATS, or robotic), intensive care requirements, and pathology depth. Below are broad, approximate price ranges across international healthcare systems.
| Country | Approximate cost range |
|---|---|
| Turkey | €7,000 – €16,000 |
| United Kingdom | €16,000 – €35,000 |
| United States | €35,000 – €85,000 |
| Germany | €15,000 – €32,000 |
Robotic consumables and prolonged ICU stays increase costs. Comprehensive packages in Turkey generally cover pre-operative consultations, chest imaging, pulmonary function tests, surgical and anaesthetic fees, theatre time, one night in intensive care if needed, four to five ward nights, routine histology, post-operative medication, and airport transfers. Request an itemised estimate through our free quote form.
Surgery compared with stereotactic radiotherapy (SBRT) and ablation
Patients often compare surgical resection with non-invasive alternatives. Treatment selection depends on tumour stage, cardiopulmonary fitness, and anatomical location:
| Treatment approach | Best suited to | Typical limits |
|---|---|---|
| Surgical resection (Lobectomy / VATS) | Medically fit patients with operable stage I–IIIA NSCLC | Requires anaesthesia, hospital stay, and sufficient breathing reserve |
| Stereotactic Radiotherapy (SBRT / SABR) | Small peripheral tumours in medically inoperable patients | No tissue specimen for nodal staging or genetic profiling; radiation risk |
| Thermal ablation (RFA / Microwave) | Small peripheral tumours under 3 cm unsuitable for surgery or SBRT | Higher local recurrence rate; restricted to small accessible lesions |
For medically fit patients, surgical resection remains the worldwide standard of care because it removes the tumour and provides tissue for comprehensive molecular analysis.
Who is a candidate for lung resection, and who is not?
Candidacy depends on both oncological operability (whether surgery can eradicate the cancer) and physiological resectability (whether the patient can tolerate lung tissue loss).
Good candidates typically present with:
- Non-small cell lung cancer (adenocarcinoma, squamous cell) at stage I, II, or selected stage IIIA without distant metastases.
- Adequate cardiopulmonary reserve confirmed by spirometry (FEV1) and carbon monoxide diffusion tests (DLCO).
- Good performance status (ECOG 0–1), enabling independent daily activity.
Surgery is generally unsuitable for:
- Stage IV metastatic cancer spread to distant organs such as the brain, liver, or bones.
- Small cell lung cancer (SCLC), which responds better to systemic chemotherapy and radiotherapy.
- Severely impaired pulmonary reserve where lung resection would cause permanent respiratory failure.
- Uncontrolled cardiovascular disease or severe heart failure.
Realistic outcomes and life after lung cancer surgery
Understanding outcomes helps patients approach surgery with clear expectations. Surgery extracts the primary tumour, but long-term health depends on histology, staging, and lifestyle modifications such as permanent smoking cessation.
Post-operative success cannot be judged by immediate chest discomfort. It is defined by the final pathology report confirming clear surgical margins (R0) and the status of dissected lymph nodes. Regular chest CT surveillance is scheduled every three to six months for two years, then annually, to detect any recurrence early.
Respiratory capacity adapts after surgery. Although patients experience initial breathlessness, the remaining lung tissue expands and compensates over three to six months. Most individuals who undergo lobectomy or segmentectomy return to walking, light recreation, and daily routines with good quality of life.
Your hospital stay in Turkey and recovery timeline
International patients travelling to Turkey for lung cancer surgery should plan a stay of 10 to 14 days. Learn more about how it works when arranging medical care abroad. Recovery progresses through defined clinical stages:
- Days 1–2 (Evaluation): Hospital admission, contrast CT or PET-CT review, pulmonary testing, cardiac clearance, and blood cross-matching.
- Day 3 (Surgery): Operation under general anaesthesia. The patient spends the first 24 hours in the intensive care unit with a chest drain in place.
- Days 4–7 (Inpatient ward): Transfer to a private room. Early walking starts on day 4 to prevent blood clots. Pain is managed with epidural or nerve blocks. The chest drain is removed once air leaks resolve and fluid levels drop.
- Days 8–12 (Hotel rest): Discharge to a hotel. The surgical team checks incision healing, reviews the pathology report, and performs a final chest X-ray.
- Day 13 onwards (Flight): The surgeon issues fit-to-fly clearance. Heavy lifting is restricted for six weeks.
Risks and complications of lung cancer surgery
Thoracic surgery involves recognized surgical and respiratory risks. Professional bodies, including the National Health Service (NHS), British Thoracic Society (BTS), and European Society of Thoracic Surgeons (ESTS), document common and serious potential complications.
Common, manageable effects include:
- Persistent air leak: Air escaping from the lung surface into the chest cavity, typically resolving within days with drain management.
- Post-operative pain: Intercostal nerve soreness around incision sites, controlled with multimodal analgesia.
- Atelectasis: Small airway collapse from shallow breathing, prevented through incentive spirometry and breathing exercises.
Less common but serious complications include:
- Cardiac arrhythmias: Particularly atrial fibrillation, triggered by chest inflammation and treated with medication.
- Pneumonia or pleural infection: Requiring targeted antibiotics.
- Deep vein thrombosis (DVT) or pulmonary embolism: Prevented with blood-thinning injections and compression stockings.
- Bronchopleural fistula: A rare failure of the bronchial stump seal requiring prompt surgical intervention.
How to choose a thoracic oncology centre and red flags
Thoracic oncology requires tertiary hospital infrastructure. Ensure the chosen hospital has dedicated thoracic intensive care units, certified thoracic surgical specialists, accredited pathology laboratories, and advanced VATS or robotic theatre facilities.
A critical quality benchmark is an active Thoracic Multidisciplinary Team (MDT), where thoracic surgeons, medical oncologists, pulmonologists, radiologists, and pathologists jointly review patient files. Submit your diagnostic scans via our free quote page for a multidisciplinary evaluation.
Watch for clinical red flags:
- Clinics agreeing to surgery without reviewing recent CT, PET-CT, and pulmonary function data.
- Facilities without on-site 24/7 thoracic ICU cover or emergency blood bank facilities.
- Guarantees of a cure or claims that thoracic surgery carries no risk.
- Brokers demanding fixed fees before the surgical team determines the exact resection needed.
Questions to ask your surgical team:
- Do you recommend VATS, robotic surgery, or open thoracotomy for my case, and why?
- What predicted breathing capacity will I retain following resection?
- Will systematic lymph node dissection be performed?
- What is the hospital's protocol if an air leak prolongs my chest drain duration?
- Will comprehensive pathology reports and treatment records be provided in English?
Hospitals with Oncology in Turkey
Frequently asked questions
Lung cancer surgery is an oncological procedure to remove a malignant lung tumour alongside surrounding healthy lung tissue and regional lymph nodes. Depending on tumour size, location, and pulmonary reserve, surgeons perform a lobectomy, segmentectomy, wedge resection, or pneumonectomy. It is the primary curative treatment for early-stage non-small cell lung cancer.
For early-stage non-small cell lung cancer, surgery offers the highest likelihood of cure. Five-year survival rates exceed 70% to 90% for stage IA tumours resected with negative margins. However, cure depends on cancer stage and whether microscopic cells have spread to lymph nodes, which is why lymphadenectomy and possible post-operative adjuvant therapies are essential.
Lung cancer surgery in Turkey typically ranges from €7,000 to €16,000, compared with €16,000 to €35,000 in the UK and up to €85,000 in the US. Pricing depends on whether an open, VATS, or robotic approach is used, pathology complexity, and intensive care duration. Hospitals confirm itemised prices in a written quote.
Before surgery, patients undergo extensive imaging and breathing tests to plan resection. After surgery, patients experience temporary breathlessness and chest soreness while recovering. Over three to six months, remaining lung tissue expands and adapts, allowing most patients to resume normal walking, light exercise, and daily activities, supported by routine follow-up CT scans.
Initial recovery in hospital lasts four to seven days, during which chest drains are monitored and removed. Most patients manage daily walking and self-care within two to three weeks. Returning to desk work usually takes four to six weeks, while full physical recovery and respiratory compensation typically settle over three to six months.
The operation is carried out under general anaesthesia, so you feel nothing during the procedure. Post-operative discomfort around incisions and chest drains is common but controlled using multimodal pain management, such as patient-controlled analgesia, thoracic epidurals, or paravertebral nerve blocks, transitioning to oral pain relievers before hospital discharge.
Surgically removing a localised lung tumour permanently eliminates that primary lesion. If clear margins and negative lymph nodes are achieved, long-term remission can be permanent. Regular chest CT scans every three to six months for two years, and annually thereafter, remain vital to monitor for potential recurrence or new nodules.
When performed in accredited thoracic surgical centres, lung cancer surgery is a well-established and safe procedure. Complications such as air leaks, pneumonia, or heart rhythm changes occur in a minority of cases and are monitored closely in hospital. Choosing an experienced thoracic surgeon and a facility with dedicated thoracic ICU cover minimises risks.
For operable early-stage lung cancer, surgery is the international standard because it removes the entire tumour and lymph nodes for accurate pathological staging. Stereotactic body radiotherapy (SBRT) is an excellent alternative for patients whose heart or lung function makes surgery unsafe, but it does not provide tissue for comprehensive molecular testing.
Patients travelling to Turkey should plan for 10 to 14 days in total. This allows one to two days for pre-operative imaging and respiratory testing, four to seven days of inpatient hospital care including chest drain removal, and several days of hotel rest before attending a final surgical check for flight clearance.
Patient stories